WonderFi Announces Addition to the CoinShares Blockchain Global Equity Index Alongside Coinbase, Galaxy Digital and Microstrategy
Toronto, Ontario–(Newsfile Corp. – April 26, 2022) – WonderFi Technologies Inc. (NEO: WNDR) (OTC Pink:…
Toronto, Ontario–(Newsfile Corp. – April 26, 2022) – WonderFi Technologies Inc. (NEO: WNDR) (OTC Pink:…
Toronto, Ontario–(Newsfile Corp. – April 26, 2022) – Cypherpunk Holdings Inc. (CSE: HODL) (OTC Pink:…
Singapore, Singapore–(Newsfile Corp. – April 26, 2022) – H.E. Justin Sun, Founder of TRON, hosted…
HONG KONG, Apr 26, 2022 – (ACN Newswire) – Legend Capital’s portfolio company Lunit, a…
By Gabriela Garner, Product Marketing Director at Kofax London 26th April, 2022: There’s no doubt…
Virtual event on Tuesday, May 3rd at 10:00 AM ET An overview of unmet medical…
Retail Pro International with Pinnaca Retail & IT Solutions, DataScan Retail Systems, RIOT, XRETAIL, Loqate,…
Internet City, Dubai–(Newsfile Corp. – April 26, 2022) – LBank Exchange, a global digital asset…
TOKYO, Apr 26, 2022 – (JCN Newswire) – Honda Motor Co., Ltd. today announced that…
Kariya, Kuwana, Japan/Hsinchu, Taiwan, Apr 26, 2022 – (JCN Newswire) – DENSO Corporation, a leading…
SINGAPORE, Apr 26, 2022 – (ACN Newswire) – Singapore’s homegrown electricity retailer Union Power Pte…
Increased sanctions, record fines for money laundering violations, and rise in tax evasion creates ‘perfect…
The combination with Sphonic will make the pan-European digital identity specialist better able to protect…
Former Abbott and Luminex executive with over 30 years of In Vitro Diagnostic (IVD) and…
The companies agree a follow-on collaboration to evaluate ViGeneron’s adeno-associated virus vectors (vgAAVs) for delivering…
Key focus on enabling prioritization and rapid progression of pipeline programs through to clinical proof-of-concept,…
Lund, April 26, 2022, Active Biotech (NASDAQ STOCKHOLM: ACTI) today announced that the European Patent…
invIOs becomes fully separate entity focused on advancing its unique EPiC cell therapy platform and…
Up to an additional $40 million made available as part of the agreement Saint–Herblain (France),…
Strong immunogenicity profile observed in study participants aged 5-17 years one month after the primary…